Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
In 18-month interim data from ongoing 2-year, Phase 2 Stargardt disease (“STGD1”) trial (“LBS-008-CT02”), we continued to observe that oral Tinlarebant is.
Tinlarebant continues to be safe and well tolerated in adolescent Stargardt Disease subjects at the 18-month time pointA continued trend of slowing expansion of autofluorescence was observedThe. | April 25, 2023